| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,348 |
2,065 |
$76K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
690 |
629 |
$42K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
986 |
763 |
$19K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
186 |
183 |
$8K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
618 |
581 |
$7K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
98 |
94 |
$4K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
104 |
92 |
$4K |
| 95115 |
|
301 |
136 |
$3K |
| 87807 |
|
123 |
118 |
$2K |
| 0072A |
|
15 |
15 |
$2K |
| 0071A |
|
13 |
13 |
$1K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
23 |
23 |
$1K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
26 |
24 |
$1K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
19 |
18 |
$1K |
| 0002A |
|
14 |
13 |
$1K |
| 85018 |
|
297 |
278 |
$861.90 |
| 85014 |
|
297 |
278 |
$861.90 |
| 90688 |
|
55 |
52 |
$702.06 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
24 |
24 |
$660.00 |
| 81002 |
|
221 |
200 |
$431.88 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
14 |
14 |
$424.40 |
| T1502 |
Administration of oral, intramuscular and/or subcutaneous medication by health care agency/professional, per visit |
54 |
42 |
$83.20 |